🇰🇷 Hanmi Pharm

30-day score trend

📊 Quant score trend

Last 30d quant score (PER/PBR/ROE/debt/margin/growth sector percentile)

PER 28.8 / PBR 4.40 / ROE 14.5% / 부채비율 50% / 이익률 16.7% / 매출성장 +3.5% / 이익성장 +33.3%

Not a buy or sell signal. Informational only.

📊 Latest earnings — 2026-06-30

Informational — not a buy signal. Source: DART

🕸️ Metrics radar

Informational — 5 axes are 0-100 percentile, compared to sector average

Market regime — 🇰🇷 KR (Korea)

SIDE "이번 주 -0.6%. 큰 움직임 없이 어깨를 한 번 으쓱한 정도였어요."

📈 7-day price

📋 Recent filings (DART)

• 08-28 최대주주등소유주식변동신고서
• 08-26 [기재정정]투자판단관련주요경영사항 (급성골수성백혈병(AML) 치료 항암신약 HM43239 기술이전 계약 체결)
• 08-24 투자판단관련주요경영사항

Source: DART (Korean electronic disclosure). Reference only.

📰 Recent news

• 기술수출 했는데 돈까지 댄다…제약업계, 해외 파트너 '자금력' 변수

  08-31 · Naver

• [코스피 지수선물 옵션] 한화에어로·효성중공업 '휘청'…삼성전자·LG전...

  08-31 · Naver

• 상반기 보수 1위 '76억' 윤상현 부회장…서정진 회장 '22억' 육박

  08-31 · Naver

Source: Naver. Not Tradory's opinion.

🔎 Compare info

Click a button to see database-backed metrics. Informational only, not buy or sell signals.

ⓘ This compares public financial and market data. Not a buy or sell opinion.